Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma.
RET
RET-inhibitor
RET-rearrangement
differentiated thyroid cancer
papillary thyroid carcinoma
pralsetinib
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
09
2022
accepted:
18
11
2022
entrez:
29
12
2022
pubmed:
30
12
2022
medline:
30
12
2022
Statut:
epublish
Résumé
We are recently faced with a progressive evolution of the therapeutic paradigm for radioiodine refractory differentiated thyroid cancer (RAI-R DTC), since the advent of tissue agnostic inhibitors. Thus, tumor genotype assessment is always more relevant and is playing a crucial role into clinical practice. We report the case of an elderly patient with advanced papillary thyroid carcinoma (PTC) harboring
Identifiants
pubmed: 36578928
doi: 10.3389/fonc.2022.1042525
pmc: PMC9792137
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1042525Informations de copyright
Copyright © 2022 Nannini, Repaci, Ricco, Ianni, Golemi, Maiolo, Ferrari, Natali, Rizzini, Monari, Solaroli, De Leo, Maloberti, Pantaleo, De Biase and Tallini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Thyroid. 2017 Feb;27(2):182-188
pubmed: 27849443
Adv Anat Pathol. 2001 Nov;8(6):345-54
pubmed: 11707626
J Clin Pathol. 2022 Jul;75(7):488-492
pubmed: 33820865
Am J Surg Pathol. 2006 Feb;30(2):216-22
pubmed: 16434896
Histopathology. 2016 Jul;69(1):45-53
pubmed: 26568156
Eur J Endocrinol. 2022 Apr 29;186(6):631-643
pubmed: 35333737
Lancet Diabetes Endocrinol. 2021 Aug;9(8):491-501
pubmed: 34118198
Mod Pathol. 2007 Jul;20(7):779-87
pubmed: 17464312
J Clin Endocrinol Metab. 2006 Sep;91(9):3603-10
pubmed: 16772343
N Engl J Med. 2015 Feb 12;372(7):621-30
pubmed: 25671254
Ann Surg Oncol. 2022 Mar 1;:
pubmed: 35230579
Genes (Basel). 2020 Apr 15;11(4):
pubmed: 32326537
Ann Surg. 2015 Sep;262(3):519-25; discussion 524-5
pubmed: 26258321
Ann Oncol. 2022 Jul;33(7):674-684
pubmed: 35491008
J Clin Endocrinol Metab. 2001 Jul;86(7):3211-6
pubmed: 11443191
N Engl J Med. 2020 Aug 27;383(9):825-835
pubmed: 32846061
PLoS Genet. 2016 Aug 05;12(8):e1006239
pubmed: 27494611
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Mod Pathol. 2020 Dec;33(12):2458-2472
pubmed: 32737449
Pathol Oncol Res. 2020 Jan;26(1):507-513
pubmed: 30467698
J Clin Endocrinol Metab. 2006 Jun;91(6):2414-23
pubmed: 16595592
Trends Cancer. 2021 Dec;7(12):1074-1088
pubmed: 34391699
Lancet. 2014 Jul 26;384(9940):319-28
pubmed: 24768112
Cancer Res. 2008 Sep 1;68(17):7176-82
pubmed: 18757433
Lab Invest. 2004 Dec;84(12):1557-70
pubmed: 15502856